Knockout Cell Series - Positive Regulation of Interferon-Alpha Production Knockout Cell Series - Positive Regulation of Interferon-Alpha Production

Interferon-α (IFN-α) is a central type I interferon involved in antiviral immunity and antitumor responses, primarily produced by plasmacytoid dendritic cells (pDCs) following viral nucleic acid recognition. Dysregulated IFN-α production is closely associated with major diseases such as viral infections (including COVID-19 and HBV), autoimmune disorders (such as systemic lupus erythematosus), and immunodeficiency syndromes. Knockout cell lines targeting the positive regulation pathway of IFN-α production enable precise investigation of TLR/IRF signaling mechanisms and therapeutic target validation. EDITGENE provides validated IRF3, IRF7, and TBK1 knockout cell models to support antiviral and immune regulation research.

IFN-α production is tightly regulated by pattern recognition receptors (PRRs) and downstream signaling cascades. Viral RNA or DNA is recognized by receptors such as TLR3/7/9 and RIG-I/MDA5, which activate the kinases TBK1 and IKKε through adaptor proteins MyD88 or TRIF, leading to phosphorylation of the transcription factors IRF3 and IRF7. Activated IRF3/7 translocate into the nucleus, bind enhancer elements, and initiate IFNA gene transcription. In addition, IRF5 and NF-κB can synergistically enhance IFN-α expression.

After secretion, IFN-α binds IFNAR receptors through autocrine and paracrine signaling, activating the JAK-STAT pathway and inducing the expression of hundreds of interferon-stimulated genes (ISGs), thereby establishing an antiviral state. Loss of IRF3/7 function impairs IFN-α production and increases susceptibility to viral infection, whereas persistent IRF7 activation is associated with autoimmune diseases such as SLE.

Knockout cell models targeting IRF3, IRF7, TBK1, and related genes provide reliable tools for dissecting the hierarchical roles of different molecules in the positive regulation of IFN-α production and support antiviral drug and immunomodulator development.

McNab et al., Nature Reviews Immunology, 2015

(McNab et al., Nature Reviews Immunology, 2015)

Abnormal expression or activity of key regulators in the positive IFN-α production pathway—including TLRs, MyD88, TBK1, IRF3/7, and IFNAR—can result in insufficient or excessive IFN-α production, contributing to diseases such as severe viral pneumonia (SARS-CoV-2 and influenza), chronic hepatitis B (HBV), systemic lupus erythematosus (SLE), psoriasis, AIDS, type I diabetes, and primary immunodeficiency disorders.

These disease contexts further demonstrate the therapeutic potential of targeting the IFN-α positive regulation pathway. Gene knockout cell models provide powerful tools for studying the functions of different regulatory factors in viral infection, autoimmunity, and tumor immune microenvironments, supporting mechanism studies, target validation, and drug discovery.

· Antiviral Drug Screening Models
Used to investigate the effects of IRF3/7 or TBK1 knockout on IFN-α induction in pDCs or fibroblasts and evaluate the immunogenicity of TLR agonists, STING agonists, and live attenuated viral vaccines.

· Autoimmune Disease Research Models
Used to study the effects of IRF7 or MyD88 knockout on pDC hyperactivation and abnormal IFN-α production, elucidate mechanisms underlying IFN signatures in SLE, and screen JAK inhibitors or IRF7 small-molecule inhibitors.

· Tumor Immunity Models
Used to investigate the effects of IFNAR1 knockout on ISG expression and antigen presentation in tumor cells and explore the role of IFN-α in antitumor immunity and resistance to immune checkpoint therapy.

· Vaccine Adjuvant Evaluation Models
Used to study the dependence of IFN-α induction by adjuvants such as CpG and R848 in TLR7/9 knockout cell lines, providing functional validation platforms for adjuvant screening and optimization.

EDITGENE’s IFN-α positive regulation pathway knockout cell line library includes validated models targeting key regulatory factors involved in IFN-α biosynthesis. We provide high-quality IRF3, IRF7, and TBK1 knockout cell lines for studying antiviral immune responses, autoimmune disease mechanisms, and IFN-related disease pathways. In addition, both ready-to-use and customized knockout cell line services are available to support diverse research needs in infectious disease immunology, autoimmunity, and tumor immunology.

Displaying Records 1 To 15 Of 119 Records
Contact Us
*
*
*
*
How did you hear about us：
✖ service online